Syndax Pharmaceuticals (SNDX)

Quick facts

Marketed products

• Revuforj · Oncology
  Revuforj works by inhibiting an enzyme that is involved in the growth and survival of cancer cells.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Syndax Pharmaceuticals portfolio CI brief
• Syndax Pharmaceuticals pipeline updates RSS